Dal Negro, R.W. et al. 2022. Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study. Multidisciplinary Respiratory Medicine. 17, (Dec. 2022). DOI:https://doi.org/10.4081/mrm.2022.886.